MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
ACTIVE_NOT_RECRUITING
Status
Conditions
- Idiopathic Pulmonary Fibrosis
Interventions
- DRUG: Axatilimab
- OTHER: Placebo
Sponsor
Syndax Pharmaceuticals
Collaborators